Citadel Advisors’s Black Diamond Therapeutics BDTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$23.4K Buy
11,000
+100
+0.9% +$238 ﹤0.01% 12632
2025
Q4
$26.5K Buy
+10,900
New +$38.6K ﹤0.01% 12266
2025
Q2
Sell
-22,100
Closed -$34.3K 12572
2025
Q1
$34.3K Buy
22,100
+19,200
+662% +$40.3K ﹤0.01% 12688
2024
Q4
$6.21K Sell
2,900
-5,100
-64% -$14.6K ﹤0.01% 13809
2024
Q3
$34.8K Buy
8,000
+7,600
+1,900% +$41.4K ﹤0.01% 12297
2024
Q2
$1.86K Sell
400
-7,300
-95% -$39.2K ﹤0.01% 13767
2024
Q1
$39K Buy
7,700
+5,100
+196% +$20.6K ﹤0.01% 12415
2023
Q4
$7.31K Sell
2,600
-15,000
-85% -$35.2K ﹤0.01% 13293
2023
Q3
$50.5K Sell
17,600
-92,600
-84% -$341K ﹤0.01% 11750
2023
Q2
$557K Buy
110,200
+102,500
+1,331% +$209K ﹤0.01% 7712
2023
Q1
$14.6K Sell
7,700
-7,300
-49% -$16.8K ﹤0.01% 13301
2022
Q4
$27K Sell
15,000
-52,200
-78% -$94K ﹤0.01% 12869
2022
Q3
$114K Buy
67,200
+27,800
+71% +$85.7K ﹤0.01% 10977
2022
Q2
$97K Buy
+39,400
New +$91.6K ﹤0.01% 11435
2021
Q4
Sell
-18,100
Closed -$153K 13798
2021
Q3
$153K Sell
18,100
-10,600
-37% -$105K ﹤0.01% 12356
2021
Q2
$350K Buy
+28,700
New +$567K ﹤0.01% 10889

Other funds holding BDTX